← Leaderboards
Paul Blum
Neurocarrus, Inc.
$3,021,555
Attributed
$3,021,555
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2020–23$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
Funding mix
By agency
NIH$3,021,555 · 2
By mechanism
R44$2,776,138 · 1
R43$245,417 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Esthesia”
- Barbara Halina Braffett · George Washington University$10,066,665
- Ionut Bebu · George Washington University$10,066,665
- Fritzie Isip Arce-McShane · University Of Chicago$8,230,803
- Lee E Fisher · University Of Pittsburgh At Pittsburgh$6,758,634
- Kathleen E Cullen · Jackson Laboratory$5,384,461
- Stephen Blumberg · National Institute On Deafness And Other Communication Disorders$4,725,000
Research focus
EsthesiaFda ApprovedClinical TrialsEngineeringExcretory FunctionAcute Pain ManagementBaseBiologicalDepolymerizationEfficacy StudyAcute PainAffectAfferent NerveAfferent NeuronsAddictionAmericanActinsAnestheticsAcuteCytoskeletonDoseDrug FormulationsAxonFuture